Literature DB >> 22054061

Current status of organ transplantation in Japan.

H Egawa1, K Tanabe, N Fukushima, H Date, A Sugitani, H Haga.   

Abstract

To overcome severe donor shortage, Japanese doctors over the years have developed innovative strategies to maximize organs transplanted per brain death donor and expanded the donor pool using living donors. They also used living and marginal organs and drastically improved living donor lung, liver, pancreas and kidney transplantations. Moreover, they initiated ABO blood type incompatible liver transplantation advancements and succeeded in overcoming the blood type barrier in kidney and liver transplantations. Similar efforts are underway for pancreas transplantation. Furthermore, Japanese doctors have developed a nonaggressive step to achieve immunosuppression following organ transplantation by carefully monitoring donor-specific hyporesponsiveness and infectious immunostatus. However, the institution of amendments to allocation systems and the intensification of efforts to decrease living donor morbidity and to increase the number of brain death donors have remained important issues needing attention. Overall, the strategies Japan has adopted to overcome donor shortage can provide useful insights on how to increase organ transplantations. © copyright 2011 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Year:  2011        PMID: 22054061     DOI: 10.1111/j.1600-6143.2011.03822.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  22 in total

1.  Liver transplantation following the Kasai procedure in treatment of biliary atresia: a single institution analysis.

Authors:  Hideyuki Sasaki; Hiromu Tanaka; Motoshi Wada; Takuro Kazama; Kotaro Nishi; Megumi Nakamura; Hironori Kudo; Naoki Kawagishi; Masaki Nio
Journal:  Pediatr Surg Int       Date:  2014-07-27       Impact factor: 1.827

2.  Organ shortage: the greatest challenge facing transplant medicine.

Authors:  David Shafran; Eric Kodish; Andreas Tzakis
Journal:  World J Surg       Date:  2014-07       Impact factor: 3.352

3.  ABO-Incompatible Living Donor Liver Transplantation in Focus of Antibody Rebound.

Authors:  Silke Rummler; Astrid Bauschke; Erik Baerthel; Heike Juette; Katrin Maier; Christina Malessa; Dagmar Barz; Utz Settmacher
Journal:  Transfus Med Hemother       Date:  2016-11-09       Impact factor: 3.747

Review 4.  Obesity and non-alcoholic fatty liver disease: Disparate associations among Asian populations.

Authors:  Robert J Wong; Aijaz Ahmed
Journal:  World J Hepatol       Date:  2014-05-27

5.  Analysis of the prognostic factors of long-term native liver survival in survivors of biliary atresia.

Authors:  Hideyuki Sasaki; Hiromu Tanaka; Motoshi Wada; Takuro Kazama; Megumi Nakamura; Hironori Kudo; Ryoji Okubo; Tsuyoshi Sakurai; Masaki Nio
Journal:  Pediatr Surg Int       Date:  2016-07-27       Impact factor: 1.827

6.  Anesthetic experience of a combined ABO- and Rh-incompatible living donor liver transplantation between an O Rh- recipient and a B Rh+ donor.

Authors:  Jaehyung Choi; Hyungseok Seo; Sung-Moon Jeong; Gyu-Sam Hwang
Journal:  Korean J Anesthesiol       Date:  2013-11

7.  Morbidity and mortality of live lung donation: results from the RELIVE study.

Authors:  R D Yusen; B A Hong; E E Messersmith; B W Gillespie; B M Lopez; K L Brown; J Odim; R M Merion; M L Barr
Journal:  Am J Transplant       Date:  2014-08       Impact factor: 8.086

8.  Transplantable liver production plan: "Yamaton"--liver project, Japan.

Authors:  Toshiyuki Hata; Shinji Uemoto; Eiji Kobayashi
Journal:  Organogenesis       Date:  2013-07-29       Impact factor: 2.500

Review 9.  Destination therapy: the new gold standard treatment for heart failure patients with left ventricular assist devices.

Authors:  Michael Yamakawa; Shunei Kyo; Sean Yamakawa; Minoru Ono; Koichiro Kinugawa; Takashi Nishimura
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-12-21

Review 10.  Current therapeutic strategies for childhood hepatic tumors: surgical and interventional treatments for hepatoblastoma.

Authors:  Tomoro Hishiki
Journal:  Int J Clin Oncol       Date:  2013-10-17       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.